MDT Stock Overview
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Harnessing Innovation And Calculated Acumen For Bright Financial Futures
US$93.2
FV
4.31%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
16 days agoauthor updated this narrative
Medtronic plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$82.21 |
52 Week High | US$89.18 |
52 Week Low | US$68.84 |
Beta | 0.83 |
11 Month Change | 6.93% |
3 Month Change | -0.76% |
1 Year Change | -1.09% |
33 Year Change | -35.53% |
5 Year Change | -19.20% |
Change since IPO | 56,399.00% |
Recent News & Updates
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Recent updates
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Medtronic: Dark Clouds Are Clearing - Outperformance Ahead
Aug 14Return Trends At Medtronic (NYSE:MDT) Aren't Appealing
Aug 11Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
Jul 15Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?
Jul 09Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter
Jun 21Is Medtronic's Dividend In A Good Place?
Jun 14Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69
Jun 03Medtronic: Solid Q4 Earnings, Don't Fret About Guidance
May 26Shareholder Returns
MDT | US Medical Equipment | US Market | |
---|---|---|---|
7D | 2.1% | 0.3% | -2.3% |
1Y | -1.1% | 4.4% | 16.7% |
Return vs Industry: MDT underperformed the US Medical Equipment industry which returned 4.4% over the past year.
Return vs Market: MDT underperformed the US Market which returned 16.7% over the past year.
Price Volatility
MDT volatility | |
---|---|
MDT Average Weekly Movement | 2.9% |
Medical Equipment Industry Average Movement | 8.4% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 14.6% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: MDT has not had significant price volatility in the past 3 months.
Volatility Over Time: MDT's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.
Medtronic plc Fundamentals Summary
MDT fundamental statistics | |
---|---|
Market cap | US$103.98b |
Earnings (TTM) | US$3.68b |
Revenue (TTM) | US$32.36b |
28.7x
P/E Ratio3.3x
P/S RatioIs MDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDT income statement (TTM) | |
---|---|
Revenue | US$32.36b |
Cost of Revenue | US$11.09b |
Gross Profit | US$21.27b |
Other Expenses | US$17.60b |
Earnings | US$3.68b |
Last Reported Earnings
Apr 26, 2024
Next Earnings Date
Aug 20, 2024
Earnings per share (EPS) | 2.87 |
Gross Margin | 65.73% |
Net Profit Margin | 11.36% |
Debt/Equity Ratio | 49.5% |
How did MDT perform over the long term?
See historical performance and comparison